Franklin Biotechnology Discovery Fund Advisor Class (FTDZX)
NASDAQ · Mutual Fund
· Delayed Price · Currency is USD
116.32
+1.66 (1.45%)
May 19, 2025, 12:19 PM EDT
-18.09% (1Y)
Fund Assets | 1.42B |
Expense Ratio | 0.80% |
Min. Investment | $1,000 |
Turnover | n/a |
Dividend (ttm) | 11.76 |
Dividend Yield | 10.26% |
Dividend Growth | n/a |
Payout Frequency | n/a |
Ex-Dividend Date | Dec 20, 2024 |
Previous Close | 114.66 |
YTD Return | -9.66% |
1-Year Return | -10.11% |
5-Year Return | -10.84% |
52-Week Low | 104.73 |
52-Week High | 160.08 |
Beta (5Y) | n/a |
Holdings | 89 |
Inception Date | Sep 1, 2009 |
About FTDZX
The Franklin Biotechnology Discovery Fund Advisor Class (FTDZX) seeks to provide capital appreciation. Under normal market conditions, the Fund predominantly invests in equity securities and invests at least 80% of its net assets in securities of biotechnology companies(at least 50% of its earnings derived from biotechnology activities) and discovery research firms.
Fund Family FrankTemp/Frank Adv
Category Health
Stock Exchange NASDAQ
Ticker Symbol FTDZX
Share Class Advisor Class
Index NASDAQ Biotechnology CR
Performance
FTDZX had a total return of -10.11% in the past year, including dividends. Since the fund's inception, the average annual return has been 9.45%.
Top 10 Holdings
49.67% of assetsName | Symbol | Weight |
---|---|---|
Vertex Pharmaceuticals Incorporated | VRTX | 7.98% |
Gilead Sciences, Inc. | GILD | 7.55% |
Amgen Inc. | AMGN | 7.37% |
Regeneron Pharmaceuticals, Inc. | REGN | 5.06% |
Ascendis Pharma A/S | ASND | 4.89% |
argenx SE | ARGX | 4.08% |
Jazz Pharmaceuticals plc | JAZZ | 3.92% |
Merus N.V. | MRUS | 3.21% |
PTC Therapeutics, Inc. | PTCT | 3.10% |
Institutional Fiduciary Trust - Money Market Portfolio | INFXX | 2.50% |
Dividend History
Ex-Dividend | Amount | Pay Date |
---|---|---|
Dec 20, 2024 | $11.7607 | Dec 20, 2024 |
Dec 20, 2022 | $0.4163 | Dec 20, 2022 |
Dec 15, 2021 | $18.0843 | Dec 15, 2021 |
Dec 15, 2020 | $10.3921 | Dec 15, 2020 |
Dec 16, 2019 | $14.1643 | Dec 18, 2019 |
Dec 17, 2018 | $4.5496 | Dec 19, 2018 |